Kyverna Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 05/15/2026 | 4.24 M | $36.63 M | -3.35% | 9.00% | |
| GILEAD SCIENCES, INC. | 05/08/2026 | 4.13 M | $35.61 M | 0.00% | 8.75% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 05/15/2026 | 3.11 M | $26.84 M | 0.00% | 6.60% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 05/15/2026 | 2.00 M | $17.26 M | 0.00% | 4.24% |
| AIGH CAPITAL MANAGEMENT LLC | 04/30/2026 | 2.00 M | $17.26 M | 33.33% | 4.24% |
| 05/15/2026 | 1.78 M | $15.39 M | 100.00% | 3.78% | |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 1.56 M | $13.42 M | -11.76% | 3.30% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 1.13 M | $9.71 M | 14.73% | 2.39% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 1.01 M | $8.68 M | 69.46% | 2.13% |
| INSIGHT HOLDINGS GROUP, LLC | 05/15/2026 | 989.05 K | $8.54 M | 0.00% | 2.10% |
| MORGAN STANLEY | 05/15/2026 | 977.29 K | $8.43 M | -2.51% | 2.07% |
| BLACKROCK, INC. | 05/13/2026 | 877.08 K | $7.57 M | 61.07% | 1.86% |
| WOODLINE PARTNERS LP | 05/15/2026 | 845.33 K | $7.30 M | 0.02% | 1.79% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 721.58 K | $6.23 M | 39.16% | 1.53% |
| PROPEL BIO MANAGEMENT, LLC | 05/14/2026 | 644.42 K | $5.59 M | -3.34% | 1.37% |
| MBB PUBLIC MARKETS I LLC | 05/15/2026 | 614.48 K | $5.30 M | 0.00% | 1.30% |
| MARSHALL WACE, LLP | 05/15/2026 | 605.51 K | $5.23 M | 346.54% | 1.28% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 577.60 K | $4.98 M | 141.85% | 1.22% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 500.00 K | $4.32 M | -70.00% | 1.06% |
| UBS GROUP AG | 05/05/2026 | 449.75 K | $3.88 M | 122.44% | 0.95% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 423.83 K | $3.66 M | 59.09% | 0.90% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 412.03 K | $3.56 M | 63.41% | 0.87% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 367.49 K | $3.17 M | 106.57% | 0.78% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 333.69 K | $2.88 M | 424.54% | 0.71% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 224.58 K | $1.94 M | 100.00% | 0.48% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 222.93 K | $1.92 M | 592.67% | 0.47% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 212.91 K | $1.84 M | 59.45% | 0.45% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 211.09 K | $1.82 M | 68.30% | 0.45% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 05/15/2026 | 200.00 K | $1.73 M | 0.00% | 0.42% |
| INVESCO LTD. | 05/12/2026 | 186.67 K | $1.61 M | 100.00% | 0.40% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 181.62 K | $1.57 M | -11.52% | 0.39% |
| SIMPLIFY ASSET MANAGEMENT INC. | 04/27/2026 | 173.11 K | $1.49 M | -10.00% | 0.37% |
| TD ASSET MANAGEMENT INC | 05/11/2026 | 169.08 K | $1.46 M | -24.11% | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2026 | 149.90 K | $1.29 M | -14.29% | 0.32% |
| SQUAREPOINT OPS LLC | 05/15/2026 | 146.98 K | $1.27 M | 5.84% | 0.31% |
| STATE STREET CORP | 05/15/2026 | 138.30 K | $1.19 M | 51.48% | 0.29% |
| BARCLAYS PLC | 05/15/2026 | 136.38 K | $1.18 M | -17.18% | 0.29% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 05/15/2026 | 134.53 K | $1.16 M | 0.00% | 0.29% |
| STIFEL FINANCIAL CORP | 05/12/2026 | 130.52 K | $1.13 M | 3.76% | 0.28% |
| Y-INTERCEPT (HONG KONG) LTD | 04/27/2026 | 114.84 K | $991.08 K | 100.00% | 0.24% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 114.40 K | $987.26 K | 52.64% | 0.24% |
| WESBANCO BANK INC | 04/21/2026 | 110.30 K | $951.89 K | 100.00% | 0.23% |
| KERA CAPITAL PARTNERS, INC. | 05/06/2026 | 108.08 K | $932.76 K | -18.49% | 0.23% |
| JANE STREET GROUP, LLC | 05/12/2026 | 104.21 K | $899.37 K | -42.77% | 0.22% |
| 683 CAPITAL MANAGEMENT, LLC | 05/15/2026 | 85.00 K | $733.55 K | -26.02% | 0.18% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 78.42 K | $676.76 K | 0.01% | 0.17% |
| NORTHERN TRUST CORP | 05/14/2026 | 78.04 K | $673.50 K | 51.33% | 0.17% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 05/13/2026 | 71.06 K | $613.24 K | -19.76% | 0.15% |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 05/15/2026 | 63.52 K | $548.14 K | 100.00% | 0.13% |
| CITADEL ADVISORS LLC | 05/15/2026 | 58.13 K | $501.63 K | -78.90% | 0.12% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Kyverna Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 132 institutional investors and hedge funds held shares of Kyverna Therapeutics Inc.. The most heavily invested institutionals were:
GILEAD SCIENCES, INC.: 4.13 M
Bain Capital Life Sciences Investors, LLC: 3.11 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 2 M
AIGH Capital Management LLC: 2 M
PRICE T ROWE ASSOCIATES INC /MD/: 1.56 M
BALYASNY ASSET MANAGEMENT L.P.: 1.13 M
73.85% of Kyverna Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 39.93 M shares in the last 24 months. This purchase volume represents approximately $335.41 M in transactions.